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RESUME 
L'utilisation de la thérapie génique dans l'approche d'un traitement des 
maladies oculaires dégénératives, plus particulièrement de la rétinite 
pigmentaire, semble être très prometteuse (Acland et al. 2001). Parmi les 
vecteurs développés, les vecteurs lentiviraux (dérivé du virus humain HIV-1 ), 
permettent la transduction des photorécepteurs après injection sous-rétinienne 
chez la souris durant les premiers jours de vie. Cependant l'efficacité du transfert 
de gène est nettement plus limitée dans ce type cellulaire après injection chez 
l'adulte (Kostic et al. 2003). L'objet de notre étude est de déterminer si la 
présence d'une barrière physique produite au cours du développement, située 
entre les photorécepteurs et l'épithélium pigmentaire ainsi qu'entre les 
photorécepteurs eux-mêmes, est responsable de la diminution de l'entrée en 
masse du virus dans les photorécepteurs, minimisant ainsi son efficacité chez la 
souris adulte. 
De précédentes recherches, chez le lapin, ont décrit la capacité d'enzymes 
spécifiques comme la Chondroïtinase ABC et la Neuraminidase X de modifier 
la structure de la matrice entourant les photorécepteurs (Inter Photoreceptor 
Matrix, IPM) par digestion de certains de ses constituants suite à leur injection 
dans l'espace sous-rétinien (Yao et al. 1990). Considérant l'IPM comme une 
barrière physique, capable de réduire l'efficacité de transduction des 
photorécepteurs chez la souris adulte, nous avons associé différentes enzymes 
simultanément à l'injection sous-rétinienne de vecteurs lentiviraux afin 
d'améliorer la transduction virale en fragilisant l'IPM, la rendant ainsi plus 
perméable à la diffusion du virus. 
L'injection sous-rétinienne de Neuraminidase X et de Chondroïtinase 
ABC chez la souris induit des modifications structurales de l 'IPM qui se 
manifestent respectivement par la révélation ou la disparition de sites de liaison 
de la peanut agglutinin sur les photorécepteurs. L'injection simultanée de 
Neuraminidase X avec le vecteur viral contenant le transgène thérapeutique 
augmente significativement le nombre de photorécepteurs transduits (environ 
cinq fois). Nous avons en fait démontré que le traitement enzymatique augmente 
principalement la diffusion du lentivirus dans l'espace situé entre l'épithélium 
pigmentaire et les photorécepteurs. Le traitement à la Chondroïtinase ABC 
n'entraîne quant à elle qu'une légère amélioration non significative de la 
transduction. 
Cette étude montre qu'une meilleure connaissance de l'IPM ainsi que des 
substances capables de la modifier (enzymes, drogues etc.) pourrait aider à 
élaborer de nouvelles stratégies afin d'améliorer la distribution de vecteurs 
viraux dans la rétine adulte. 
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Gene transfer offers a substantial promise for the therapy of 
degenerative ocular diseases. Lentiviral vectors have the 
ability to efficient/y transduce murine photoreceptors during 
the first days of /ife, but they are poorly effective on 
photoreceptors during adulthood. Here, we studied whether 
a physical barrier was responsib/e for this impairment. 
Previous studies have described the capacity of enzymes, 
such as chondroitinase ABC and neuraminidase X, to modify 
the structure of the interphotoreceptor matrix (/PM) when 
subretinally injected. Considering the /PM as a physica/ 
barrier that may decrease photoreceptor transduction, we 
injected different enzymes into the subretinal space of the 
adult mouse simultaneously with the lentiviral vector pre-
paration, to increase viral transduction by fragilizing the /PM. 
Keywords: gene transfer; retina; lentivirus; neuraminidase 
Retinitis pigmentosa, characterized by a loss of photo-
receptors, appears to be a target of choice for gene 
therapy, because of the accessibility of the retina and 
because several types of retinitis pigmentosa are mono-
genic diseases in which a single mutation leads to a loss 
of function. The consecutive retinal degeneration is 
indeed often due to mutations of genes expressed in 
photoreceptor cells,1 but also due to the dysfunction of 
the pigmented epithelium (RPE) .2 As several retinal 
d egenerative diseases are a consequence of a genome 
alteration affecting specifically photoreceptors, it is of 
prime importance to efficiently and specifically target 
these cells. Severa! studies have shown that gene therapy 
is a promising tool to correct gene defects affecting 
the retina or to rescue retinal cells.3-12 By transferring 
therapeutic genes into RPE cells with viral vectors, 
s tudies have also demonstrated vision recovery in large 
animal h1odels suffering from retinitis pigmentosa, such 
as dogs.6,10.13 
The lentiviral vector ability to transduce photorecep-
tors has been demonstrated,3.4- 14 but its therapeutic effect 
was documented only for pos tna tally-treated mice.4 
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Subretinal injection of neuraminidase X and chondroitinase 
ABC induces modifications in the /PM by, respective/y, 
revealing or decreasing peanut agglutinin sites on photo-
receptors. The simultaneous subretinal injection of neurami-
nidase X with a lentiviral vector driving the expression of 
a reporter gene in the photoreceptors increases the number 
of transduced cells significantly (around five-fold) . After the 
enzyme treatment, the diffusion of the vector between the 
pigmented epithelium and the photoreceptors appears to 
facilitate the lentiviral vector transduction. Such approach 
targeting the /PM may help to design new strategies to 
improve gene delivery into the adult photoreceptors. 
Gene Therapy (2005) 12, 942-947. doi:10.1038/ 
sj.gt.3302485; Published online 17 March 2005 
No data show whether a lentiviral vector can have a 
beneficial action on adult photoreceptors, whereas in 
adult-trea ted rats, retinal ga nglion cells can be preserved 
by transgene delivery mediated by a lentiviral vector.72 
In the adult rat, transduction of the photoreceptors is 
confined to the injection site,3 and in the mouse the 
percentage of transduced photoreceptors is low.14 More-
over lentiviral transduction of photoreceptors seems 
more effici ent in newborn and nonmature retinas than 
in adult mice after either intravitreous or subretinal 
injection.3.4· 14 Therefore, obstacles that prevent an effi-
cient transduction of photoreceptors by the lentiviral 
vector may exist. One possibility is that the interphoto-
receptor matrix (IPM), which occupies the space between 
the neural retina and the RPE, could play a role as a 
physical barrier. IPM is composed of domains associated 
with cone photoreceptors, termed 'cone matrix sheaths', 
composed of proteoglycan containing chondroïtin sulfate 
and oligosaccharides. They are interconnected with 
oligosaccharides and proteoglycans, which have term-
inal sialic acid residues associated with rod photorecep-
tors. The cone matrix sheaths form a structural and 
molecular bond between the photoreceptors and the RPE 
microvilli. 15 
Yao et a/16 have demonstrated that, in the rabbit, 
subretinal injections of specific enzymes (neuraminidase 
1 
1 1 
1 ] 
1 1 
[ 1 
1 1 
1 J ,I 
1 1 
[ 1 
[ 1 
1 1 
[ 1 
[ 1 
[ 1 
[ 1 
[ J 
[ 1 
1 J 
1 1 
[ 1 
[ 
X and chondroitinase ABC) significantly decrease retina 
adherence to the RPE by changing the IPM structure. 
Indeed, the neuraminidase X removes the sialic acid 
residues, w hereas the chondroitinase ABC digests 
proteoglycans . The use of the peanut agglutinin (PNA) 
binding affinity in the retina enabled the observa tion of 
certain p roperties of those enzymes. PNA binds with 
high affinity to galactose-galactosamin disaccharides 
present in the IPM domains associated with cones. For 
rods, sia lyl residues mask these carbohydrate chains and 
prevent the binding of PNA. Neuraminidase X digests 
the sya lic acid residues and so reveals the galactose-
galactosamin disaccharides, allowing new accessible 
binding sites for the PNA. By contrast, chondroitinase 
ABC treatment of the retina leads to a decrease in PNA-
binding site number by removing the proteoglycans. 
In the present study, we have tested whether the 
diffusion of the lentiviral vector is impaired by a physical 
barrier and whether this barrier is detennined by the 
presence of proteoglycans and sialic acid residues. 
To evalua te the efficiency of gene transfer by lentiviral 
vectors into the photoreceptor layer of the adult mouse, 
we performed lentiviral vector injections into the vitre-
ous and subretinal space in different groups of animais. 
When adult mice were injected intravitreously with a 
len tiviral vector encoding the GFP transgene under the 
control of the rhodopsin promoter (LV-Rho-GFP), none 
or rare cells expressed GFP 7 days after the injection as 
reported previously. 1 '1 In contrast, the subretinal ap-
proach allowed to transduce more photoreceptors, but 
only in the vicinity of the injection site. Nonetheless, 
despite the fact that the subretinal injection improved 
photoreceptor transd uction efficiency, only a low per-
centage (1-3%) of the total photoreceptor population at 
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the site of injection expressed the transgene. We 
hypothesized tha t a physical barrier may prevent the 
viral vector diffusion, this barrier being between the 
photoreceptor and the RPE layers, as well as between 
photoreceptors themselves. Supporting this hypothesis, 
the bes t transduction efficiency was observed in areas 
where the photoreceptor layer was disturbed by the 
injection procedure, as was already observed in our 
precedent work. 14 Interestingly, when LV-PGK-LacZ, LV-
EFs-GFP (previously shown to transduce RPE cells14), or 
LV-Ubi-GFP vectors were injected subretinally (n = 24), 
a large portion of the RPE cells were positive for the 
transgene over a distance of 1.37±0.15 mm, whereas 
rhodopsin-GFP-expressing cells were observed covering 
a length of 0.9 ± 0.19 mm (n = 9), the total length of the 
retina being around 3.5 mm. These results suggest that 
the virus has a certain accessibility to the subretinal 
space, but has difficulty in targeting photoreceptors. 
To detennine whether a physical barrier prevents the 
subretinally injected vectors from reaching the photo-
receptors in massive amounts, we investigated how 
proteoglycans maintain the rigidity of the outer nuclear 
layer (ONL) in the mouse by testing whether the co-
injection of neuraminidase X or chondroitinase ABC with 
LV-Rho-GFP increases the lentiviral transduction of 
photoreceptors. 
To monitor the changes in the photoreceptor cell 
layers, we used PNA coupled to a dye (Texas red) or to 
biotin (for revelation using DAB proced ure). In the 
enzyme-untrea ted tissue, PNA binds preferentially to 
the terminal sugar of the cones (Figure la). However, the 
injection procedure itself has an impact on PNA binding 
to the outer segments (perhaps due to the detachment of 
the retina from the RPE) because injection of the vehicle 
Figure 1 PNA-bi11di11g sites after s11bretinal injection of newm11inidase X and chondroitinase ABC i11 1110use eyes . Gro11ps of 111ice (n = 7-9 per group) 
received subretinal i11jections of 1.5 1il of newmninidase X (50 U/111 /, Roche, Switzer/and), or of c/10ndroitinnse ABC (0.2 Ll/111 /, Seigakac/n1, /apan) or of 
vehic/e (PBS contai11ing 0.5% BSA), as described previously.1• Mice were kil/ed 1 or 3 days post-injection, their eyes fixed by immersion in 4% 
parafon11a/dehyde in PBS, cryoprotected in s11crose and rnt in 15 µ111 slices with a cryostat. After blocking the nonspecific binding sites of eye sections, PNA 
labeling was pe1for111ed overnight al 4°C using PNA coupled with Texas red (1:5000, Sigma) or with biotin (1:100, Sigma) and then washed three limes 
with PBS. PNA nffinity in the co11trol eyes injected with the vehic/e 011 /y is directed towards cane outer segments (a, arrow), as was described by Yao el 
n/1 6•21 in the rabbi!. However, the mosf externat pari of these segments (a, brackets) shows an i11crease in PNA bi11ding co1npared Io 11ninjected eyes (nof 
shown), which may be a consequence of the retinal detachmenf induced by the subrefinal i11jection. At 1 day (b) or 3 days (nof shown) after neura111inidase X 
injection , the PNA-bi11ding affinity is modified and there is an increase in PNA binding in the 011/er segment layer (b, arrow) al the site of injection or in the 
vicinity of the injection site where the neural reti11a is still 11ttac/1ed to the RPE. On the olher hand, 1 day (c) or 3 days (not sl10wn) after chondroitinase ABC 
injection, the PNA nffinity for cane outer segments is /ost nt the i11jection site (c , arrow s/wwing a remaining PNA-binding site), but 011 /y decreased in the 
neighborhood of the injection site (not slwwn). The boundan; of the region where there are PNA-binding site modifications fo llowing c/10ndroitinase ABC 
h"eafmenf is shown in (d). The arrow shows the typical PNA binding in the untreated region a11d the asterisk defines the region where the PNA labeling is 
decreased in the inner segment. The dotted line helps Io separafe the most externat part of the outer segments, which shows an increase in PNA /abeling 
independently of enzyme treat1nent (see a). In conclusion , the subretinal injection of neuraminidase X and chondroitinase ABC in the 1no11se retina allers 
the integrity of the IPM. (a - c) PNA labe/ing in red a11d Dapi s faining in blue. (a-c) x 400 magnification; (d) x 200 magnification. 
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Figure 2 Ne11m 111i11id11se X 1111d c/10ndroiti1111se ABC co-injectio11 with le11tiviml vectors does not illlpnir photoreceptor tmnsduction. The 1-/lox-Rlw-GFP 
(LV-Rho-GFP) vector construction, production 11nd qu11ntific11tio11 were previously described in Kostic et 111. 1•1 In the first gro11p of 11ni11111ls (n = 9), we 
m;ected the eq11iv11 lent of 150 ng of p24 per eye (1.5 pl), which w11s esti11iated previously'" Io correspo11d to 11ro1111d 2.6 x 106 tmnsduction units for this 
vector. ln the Iwo ol/1er groups, the s11111e 11111011n l of LV-Rl10-GFP w11s co-i11jected with the s11 1ne 11111ount of either ne11m111inid11se X (n = 8) or chondroitin11se 
ABC (n = 7) used i11 the preceding experi11ie11f (Fig ure 1) with the s11111e injection vo/11111e per eye (1.5 pl). At 7 d11ys post-injectio11 of LV-Rho-GFP (11, b, c, i) 
or of 11 L\1-Rho-GFP sol11tio11 with ne1/l'11111inid11se X (d, e, f) or chondroitil111se ABC (g, Il), we observed cel/ tmnsduction (GFP-positive cells, green) i11 the 
ONL (11, b, d, e, g, h 11rrow) nt the injectio11 site. (c) 11nd (f) show co-l11beling of PNA with GFP fl uorescence in eyes injected, respective/y, with LV-Rho-GFP 
011ly or LV-Rho-GFP+ne11m111i11id11se X. At 7 d11ys 11fter injection of 11eura1ninid11se X, the PNA-binding site pattern is not yet recovered. (i) shows that 
GFP-expressing cel/s hnve 11plwtoreceptor111orpl10logy. Th us, co-injection of these enzymes does not hinder Ientiviml tmnsd11ctio11. lnterestingly, LV-Rlw-
GFP co-injected with neum 111 inid11se X 11ppe11rs ta enh11nce the size of the region surrounding the injection site benring GFP-positive cel/s. (11, d, i) GFP 
fluorescence; (b, e, h) GFP fluorescence in green 11nd Dnpi st11ining in bl11e. M11g11ificnt ion: (11, b, d, e, g, f, i) x 400; (c, f) x 200. 
only (Figure 1a) leads to an increase of labeling in the 
most external part of these segments in comparison to 
uninjected eyes (not shown). According to Yao et a/, 16 
subretinal injection of neuraminidase X in the rabbit 
leads to an increase in the number of PNA-binding sites, 
whereas chondroitinase ABC injection decreases the 
binding of PNA. We first injected the enzymes alone 
into the subretina l space of adult mice (neuraminidase X 
or chondroitinase ABC) and killed the animais 1 or 3 
days post-injection. The eyes were cryosectioned, labeled 
with Texas red-linked PNA and analyzed with fluor-
escent microscopy or labeled with biotin-linked PNA 
and analyzed under direct light microscopy. Following 
neuraminidase X treatment, the PNA-binding sites 
available increased markedly. The labeling was observed 
throughout the outer segment layer (Figure 1b) and was 
mostly visible at the level of the inner segments of the 
photoreceptors (Figure 1b, arrow). The binding sites 
were so dense that it was impossible to count individua l 
outer segment labeling. By contrast, after chondroitinase 
ABC injection, we observed a loss of PNA binding to the 
cone matrix sheaths, mostly to the inner segments, at the 
injection site (Figure 1c). The number of PNA-labeled 
canes was significantly decreased at the injection site 
(Figure 1c) in comparison to regions far away from the 
injection site (Figure 1d). 
The present results show that neuraminidase X and 
chondroitinase ABC lead to changes in the IPM structure 
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of mouse retina, as was observed in the rabbit1 6 (1992). 
We then tested whether subretinally injected enzymes 
lead to IPM changes that could facilitate lentiviral 
transduction of photoreceptors. LV-Rho-GFP and either 
neuraminidase X or chondroitinase ABC were mixed and 
injected into the adult mouse subretinal space. The mice 
were killed 7 days post-injection and the number of 
transduced photoreceptors was analyzed under fluores-
cent microscopy to detect GFP-expressing cells. Impor-
tantly, we observed that both neuramirudase X and 
chondroitinase ABC did not interfere with lentiviral 
vector infection, showing that this enzyme has no 
inhibitory effect on the use of this type of viral vector 
(Figure 2). Moreover, neuraminidase X significantly 
improved photoreceptor transduction. It increased by 
about five-fold the number of GFP-positive photorecep-
tors (Figure 3a). Chondroitinase ABC had a tendency to 
improve photoreceptor transduction (Figure 3a). How-
ever, this effect was not significant. Thus, it appears that 
the disruption of the IPM by specific enzymes leads to the 
improvement of lentiviral diffusion and infection. These 
experiments also reveal that the sialic acid residue is an 
essential component for the integrity of the interconnec-
tions of the outer segments and their adhesion to RPE. 
Neuraminidase X has two different effects on the 
rabbit retina. It increases its detachment from the RPE 
and modifies the IPM structure.16 To determine the 
extent of neuraminidase X action, we compared the 
number of sections per eye bearing GFP-positive photo-
receptors with and without simultaneous injection of 
neuraminidase X (Figure 3b). This number reflects the 
diffusion of the virus under the subretinal space. When 
neuraminidase X and LV-Rho-GFP were co-injected, the 
number of GFP-positive photoreceptors increased in 
correlation with the number of GFP-positive sections 
(Figure 3). The enzyme increased the retinal detachment 
by forming a bleb which spread over the ONL evenly, 
separating the retina from the RPE. The density of GFP-
positive photoreceptors was not increased at a precise 
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site of the retina: there is no statistically significant 
difference between the eyes injected with LV-Rho-GFP 
only, which have on average 2.5% of the photoreceptors 
at the region of the ONL bearing the GFP signal that was 
GFP-positive (67 GFP-positive cells out of 2860 photo-
receptor cells), and the eyes treated with LV-Rho-GFP+ 
neuraminidase X which have 4% of GFP-positive cells 
in similar regions (three microscopie fields containing 
GFP-positive cells for four eyes were counted: 305 GFP-
positive cells over 7660 photoreceptors). Nevertheless, 
the total surface of transduction increased under the co-
incubation with the enzyme (Figure 3c). This shows that 
neuraminidase X improves lentiviral vector transduction 
in the subretinal plan. 
Previous studies have demonstrated that the integra-
tion of a therapeutic transgene into a degenerating retina 
can delay its degeneration and apoptosis of its cells.4-7,9 - 12 
Use of specific promoters enables the transgene to target 
a precise cell type, thus avoiding its expression in the 
neighboring different cell phenotypes.4 -14-17 To observe 
the transduction of photoreceptors by lentiviral vectors, 
we used the promoter controlling the rhodopsin 
gene.14-1 8 Our and other groups have shown that the 
lentiviral vector is poorly efficient to transduce photo-
receptors in the adult rodent retina,1 4 ' 19 whereas photo-
receptors of young animais are more easily 
transduced.4 ,1<1 This difference could be due to several 
parameters. In particular, a change in gene expression 
might occur after the full development of the retina. In 
the present case, the rhodopsin promoter is active all 
along adult life and the rhodopsin gene is expressed 
already at birth. The change of expression of a vector 
inserted in the genome can be due to a change of 
chromatin folding, but such a change rarely occurs in 
post-mitotic adult cells. This suggests that the reduced 
lentiviral transduction in the adult photoreceptor is 
probably due to a decrease of virus accessibility to its 
target. In the adult eye, we can envisage that RPE cells 
have a greater activity in comparison to the newborn eye 
OLV-GFP c 
•LV-GFP + N 
injection site 
retina retlna 
LV·Rho-GFP LV-Rho-OFP 
+ Neuraminidase 
Figure 3 Neurami11id11se X treatment of mouse subretinal space significantly increnses plwtoreceptor transduction by LV-Rlw-GFP. (a) Neuraminidase 
X tre11t111e11t (11 =8) signific11 ntly i11creases the number of photoreceptors tra11sd11ced by LV-Rho-GFP (P <0.05), where11s chondroitinase ABC (11 = 7) has 
011/y a tendency ta increase photoreceptor transduction. (b) We counted the 11u111ber of GFP-positive sections per eye Io eva/u11te the diffusion of the lentiviral 
transduction. Stntistical analysis reveals thnt neuraminidase X treatment incre11ses the diffusion of the lentiviral vectors in the subretinal space 
(in comparison Io LV-Rho-GFP on/y injection, P <0.05) in correlation with the i11cre11se of the number of transduced plwtoreceptors. (c) Di11gm 111 showing 
th11t the increase of GFP-positive photoreceptor number using 11e11raminid11se X tre11t111e11 t is due ta 11n incrense in the diffusion of the le11tiviral vectors from 
the injection site into the s11breti1111/ plan 11nd not due ta an increase of transd11ction rate 111 the i11jection site. LV-GFP: /entivirns Rlw-GFP injectwn, 
LV-GFP+N: lentivirns Rlzo-GFP and neuraminidase X i11jection, LV-GFP+C: le11tivir11s Rho-GFP and chondroitinase ABC i11ject io11, 'P <0.05 versus 
LV-GFP. 
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and that the majority of the viral vectors injected 
subretinally is phagocyted by the RPE cells. The fact 
that adult RPE cells are well transduced in a large area 
shows that the lentiviral vector canin part disperse in the 
subretinal space. Thus, a certain amount of vector should 
be available also for photoreceptors. The mean coverage 
of RPE transduction by vectors targeting the expres-
sion in the RPE is about 1.37±0.15 mm in length, 
whereas photoreceptor transduction occurred on only 
0.9 ±0.19 mm. Moreover, the photoreceptors were trans-
duced only sparsely and not sicle by sicle as observed in 
the RPE, showing that the ONL is reached with difficulty 
by the lentiviral vector. However, the neuraminidase 
X treatment increased the number of transduced photo-
receptors (five-fold) and the distance to which cells 
were infected (1.7 mm) . These results clearly show that 
a physical barrier impairs lentiviral diffusion into the 
subretinal space and the ONL when the retina is intact. 
The removal of the sialyl residues by neuraminidase 
X allows to disrupt the cell attachment between photo-
receptor outer segments, as revealed by PNA staining. 
This release of photoreceptor connection allows the 
lentiviral vector to penetrate the ONL, but not evenly 
in all photoreceptor layers. Digestion of proteoglycans by 
chondroitinase ABC was less effective, probably because 
it mainly disrupts the matrix secreted by the cones, 
which represent only 3% of the photoreceptor population 
and thus contribute only weakly to the physical barrier 
that the IPM seems to represent for viral particles. This 
demonstrates that neuraminidase X has a major action 
on adherence between photoreceptors and reveals that 
lentiviral vector diffusion into the adult retina, and more 
specifically into the ONL, is impaired by components of 
the IPM. As neuraminidase X has no effect in deeper layers 
of photoreceptors, our results suggest that other compo-
nents of the IPM or cellular structures like glial extension 
forming the outer lirniting membrane20 may prevent the 
lentiviral vector to diffuse between photoreceptors. 
These observations have important consequences on 
the potential use of the lentiviral vector to replace genes 
in the adult photoreceptors. Indeed, Yao et a/21 showed 
that these retinal enzymatic treatments do not impair the 
functional retinal recovery of rabbit retina after the 
surgical act. Similarly, we observed no differences in 
ERG recordings between mouse eyes injected with 
lentiviral vector only or in the presence of such enzymes 
(Figure 4), which render this approach compatible with 
potential gene transfer therapies. However, even with the 
partial digestion of the IPM, the efficiency of photo-
receptor transduction remains quite low. In this case, 
only around 4% of the photoreceptors are transduced in 
the regions reached by the vector, hiding a potential 
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Figure 4 Retinal ftmction of s11bretinally i11jected mice is not affected by 11e11ra111inidase treat111e11t. (a) Scotopic ERG of dark-adapted micd11 = 4) i11jected 
i11 011e eye witlr LV and in tl1e contralateral eye wit/1 LV a11d ne11ra111inidase X was 111eas11red 1 week post-i11jection 11sing single flashes of increasing 
i11te11sities (fro111 10- • Io 25 cds/1112). The amplitudes a11d the i111plicit limes of a- and b-wave responses are reported in the Iwo 11pper graphs slzowing t/11 
similarity of the responses between both gro11ps (LV or LV +N). Similar responses between both gro11ps were also obtained for scolopic flicker responses 11sit1S 
repeated 3 cds/111
2 
f1asl1es of i11creas i11g freq11 encies (from 0.5 Io 30 Hz) or for plwtopic responses (data not slww11) . (b) Representative scotopic si11gle-f1a sh 
responses 7 weeks post-injectio11 of a 111011se injected in one eye with LV 011ly and i11 t/1e contralateral eye with LV +N. LV: lentiv ir11s Rlw-GFP i11jectio11, 
LV+N: lenlivirus Rho-GFP and neurami11idase X i11ject ion. 
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effective b~nefit due to transgene integration. Nonetheless, 
our expenments show that manipulation of the IPM 
barrier may irnprove lentiviral vector cell transduction and 
that the prospect of other enzymes or substance targetin 
the IPM shoul~ help to enhance lentiviral vector-mediateâ 
gen~ transfer mto_ photoreceptors. So, identifying more 
preosely the conshtuents of the IPM and the structu f 
the ONL m.ay give new strate~ies for increasing Jenti~r~l 
vector-med1ated gene transfer mto photoreceptors. 
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